Midas Rex
Payments companies reported to CMS as associated with Midas Rex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Midas Rex, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Midas Rex
These are the largest totals companies reported as associated with Midas Rex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joe Kutz | Dallas, TX | Otology & Neurotology | $34,998.49 |
| Vijay Agarwal | Rochester, MN | Neurological Surgery | $26,508.14 |
| Kevin Foley | Memphis, TN | Neurological Surgery | $26,362.00 |
| Franco De Monte | Houston, TX | Neurological Surgery | $25,164.39 |
| Juan Fernandez-Miranda | Stanford, CA | Neurological Surgery | $24,936.65 |
| Brandon Isaacson | Dallas, TX | Otology & Neurotology | $23,998.23 |
| Shaan Raza | Houston, TX | Neurological Surgery | $21,258.06 |
| David Altschul | Bronx, NY | $20,982.63 | |
| Michael Lang | Phoenix, AZ | Neurological Surgery | $20,190.47 |
| Timothy Ryken | Des Moines, IA | Neurological Surgery | $19,558.57 |
Prescribed Midas Rex?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.